Cincinnati Children's Vector Production Facility
Cincinnati, OH
National Center
1 confirmed programs
· 1 sponsors
· Last scored 2026-10-29
75.1
Signal Score
✓ FDA Inspections (2)
✓ Clinical Trials (1)
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Cincinnati Children's Vector Production Facility
- Signal Score
- 75.1/100 (as of 2026-10-29)
- Quality Compliance
- 99.6/100
- Headquarters
- Cincinnati, OH
- Modalities
- AAV, Lentiviral
- Active Programs
- 1 confirmed from ClinicalTrials.gov across 1 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cincinnati Children's Vector Production Facility
CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
99.6
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-02-05)
Operations
60.0
1 active programs across 1 sponsors
Modalities: AAV, Lentiviral
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
1 active programs across 1 sponsors · Modalities: AAV, Lentiviral · 1 programs in advanced phases (Phase 2/3)
Programs
1
Sponsors1
ModalitiesAAV, Lentiviral
1 active programs across 1 sponsors
Modalities: AAV, Lentiviral
1 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Financial Stability
68.0
Parent company: Cincinnati Children's Hospital
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Cincinnati Children's Hospital
Financial assessment: 68.0/100
Capacity
58.0
1 manufacturing site: Cincinnati, OH
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100
Sites: Cincinnati, OH
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Cincinnati, OH
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100
Cincinnati Children's Vector Production Facility FDA Inspection History
2025-02
2023-07
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-02-05 |
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Not posted | No Action Indicated (NAI) |
| 2023-07-12 |
Cincinnati Childrens Hospital Medical Center
Cincinnati, Ohio
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Cincinnati Children's Vector Production Facility FDA 483 Findings 2 observations · 2023-07-12 → 2023-07-12 ?
By subsystem
By severity
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Kits not FDA approved, specifically labeled
"Communicable disease agent tests were not FDA-licensed, approved or cleared donor screening tests."
-
Risk factors, clinical evidence
"Donors were not screened by a review of relevant medical records for risk factors of communicable disease agents and diseases."
Clinical Activity 1 studies
Source: ClinicalTrials.gov · Retrieved Nov 21, 2026
Hiring Activity 2 open roles Beta
From public job postings on the parent company's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
2
open roles
2
in manufacturing, quality, PD/MSAT, engineering or regulatory (100%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 504 taken down.
By function
By site
Cincinnati, Ohio, United States of America / Cincinnati, Ohio, United States of…
profile site
2 mfg/ops 2
2 mfg/ops 2
Modality words in job titles
Cell therapy / CAR-T2
Latest postings
GXP Technician I Applied Gene Cell Therapy Center Operations Controls Support
Manufacturing & operations · Cincinnati, Ohio, United States of...
GXP Specialist or Technician I II Applied Gene Cell Therapy Center
Manufacturing & operations · Cincinnati, Ohio, United States of America
Coverage: read from the parent company's careers board and kept only postings at this business's sites (hospital-wide board; titles naming the Applied Gene and Cell Therapy Center, GXP/GMP, vector or cell-manufacturing work). Roles outside those sites are left out, and some of this unit's roles may be missed.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
jobs.cincinnatichildrens.org
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Frequently Asked Questions About Cincinnati Children's Vector Production Facility
How many FDA inspections does Cincinnati Children's Vector Production Facility have on record?
CDMO Signal tracks 2 FDA inspections for Cincinnati Children's Vector Production Facility, sourced from the FDA inspection database. See the full inspection history above.
Has Cincinnati Children's Vector Production Facility received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Cincinnati Children's Vector Production Facility.
How many clinical programs is Cincinnati Children's Vector Production Facility linked to?
Cincinnati Children's Vector Production Facility is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is Cincinnati Children's Vector Production Facility's CDMO Signal Score?
Cincinnati Children's Vector Production Facility has a Signal Score of 75/100, based on quality, operations, financial stability, and capacity data.
Evaluating Cincinnati Children's Vector Production Facility for a manufacturing program?
Use the free AI matchmaker to compare Cincinnati Children's Vector Production Facility against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Andelyn Biosciences
Columbus, OH
Signal Score: 63.0
AAV, Lentiviral, Plasmid DNA
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
Compare Cincinnati Children's Vector Production Facility with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.